Your browser doesn't support javascript.
loading
Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial.
Koshino, Akihiko; Neuen, Brendon L; Jongs, Niels; Pollock, Carol; Greasley, Peter J; Andersson, Eva-Marie; Hammarstedt, Ann; Karlsson, Cecilia; Langkilde, Anna Maria; Wada, Takashi; Heerspink, Hiddo J L.
Affiliation
  • Koshino A; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands.
  • Neuen BL; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan.
  • Jongs N; The George Institute for Global Health, UNSW Sydney, Sydney, Australia.
  • Pollock C; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands.
  • Greasley PJ; Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Sydney, Australia.
  • Andersson EM; Royal North Shore Hospital, St Leonards, NSW, Australia.
  • Hammarstedt A; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.
  • Karlsson C; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.
  • Langkilde AM; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.
  • Wada T; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.
  • Heerspink HJL; BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.
Cardiovasc Diabetol ; 22(1): 330, 2023 11 28.
Article in En | MEDLINE | ID: mdl-38017482

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic Limits: Humans Language: En Journal: Cardiovasc Diabetol Journal subject: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic Limits: Humans Language: En Journal: Cardiovasc Diabetol Journal subject: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Year: 2023 Document type: Article Affiliation country: